Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
BML-210 is a novel HDAC inhibitor
lifespan extension in mice
InChi: InChI=1S/C21H25N/c1-21(2
Smiles: CSCC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@@H](N)CC1C=CC(O)=CC=1)C(C)C)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O
Formula: C34H32FeN4O4
Bromocriptine mesylate opanoic acid BML-210 is a novel HDACBromocriptine mesylate is a potent dopamine D2 D3 receptor agonist, which binds D2 dopamine receptor with pKi of 8. 050. 2. Product information CAS Number: 22260 51 1 Molecular Weight: 750. 70 Formula: C33H44BrN5O8S Chemical Name: (4R,7R) 10 bromo N [(1S,2S,4R,7S) 2 hydroxy 7 (2 methylpropyl) 5,8 dioxo 4 (propan 2 yl) 3 oxa 6,9 diazatricyclo[7. 3. 0. 0,]dodecan 4 yl] 6 methyl 6,11 diazatetracyclo[7. 6. 1. 0,. 0,]hexadeca 1(16),2,9,12,14 pentaene 4
US$ 25.00
US$ 99.00
US$ 30.00
US$ 25.00
US$ 28.00